Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum Vitamin D status

Prostate

Volumn 75, Issue 13, 2015, Pages 1376-1383

  Paller, C J ^a   Kanaan, Y M ^b   Beyene, D A ^b   Naab, T J ^b   Copeland, R L ^b   Tsai, H L ^a   Kanarek, N F ^c   Hudson, T S ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b HOWARD UNIVERSITY CANCER CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

African American; prostate cancer; quercetin; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; FOLIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; QUERCETIN; SELENIUM; VITAMIN D;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FOOD FREQUENCY QUESTIONNAIRE; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; UNIVERSITY HOSPITAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; BLOOD; DIET; ETHNOLOGY; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK;

ADULT; AFRICAN AMERICANS; AGED; DIET; DIETARY SUPPLEMENTS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUERCETIN; RISK; VITAMIN D;

EID: 84939269760     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23018     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics. CA Cancer J Clin 2013; 63: 11-30.
2. Uzzo RG, Brown JG, Horwitz EM, Hanlon A, Mazzoni S, Konski A, Greenberg RE, Pollack A, Kolenko V, Watkins-Bruner D,. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU Int 2004; 93: 955-960.
3. Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R, Morton G, Danjoux C,. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis. J Urol 1999; 161: 1521-1524.
4. Klein EA, Thompson IM, Jr., Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Baker LH,. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306: 1549-1556.
5. Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J,. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med 2007; 4: e103.
6. Murphy AB, Nyame Y, Martin IK, Catalona WJ, Hollowell CM, Nadler RB, Kozlowski JM, Perry KT, Kajdacsy-Balla A, Kittles R,. Vitamin D deficiency predicts prostate biopsy outcomes. Clin Cancer Res 2014; 20: 2289-2299.
7. Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, Martin RM,. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade. Int J Cancer 2012; 131: 1187-1196.
8. Yaturu S, Zdunek S, Youngberg B,. Vitamin d levels in subjects with prostate cancer compared to age-matched controls. Prostate Cancer 2012; 2012: 524206.
9. Holt SK, Kolb S, Fu R, Horst R, Feng Z, Stanford JL,. Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis. Cancer Epidemiol 2013; 37: 666-670.
10. Albanes D, Mondul AM, Yu K, Parisi D, Horst RL, Virtamo J, Weinstein SJ,. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev 2011; 20: 1850-1860. http://www.cancer.gov/cancertopics/factsheet/prevention/vitamin-D
11. Freedland SJ, Isaacs WB,. Explaining racial differences in prostate cancer in the United States: Sociology or biology? Prostate 2005; 62: 243-252.
12. Harris SS,. Vitamin D and African Americans. J Nutr 2006; 136: 1126-1129.
13. Topiwala S,. 25-hydroxy vitamin d test. Medline Plus Dec 2013; 27.
14. Tseng M, Giri V, Bruner DW, Giovannucci E,. Prevalence and correlates of vitamin D status in African American men. BMC Public Health 2009; 9: 191.
15. Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, Bekkering GE, Fraser WD, Sterne JA, Metcalfe C,. Associations of circulating and dietary vitamin D with prostate cancer risk: A systematic review and dose-response meta-analysis. Cancer Causes Control 2011; 22: 319-340.
16. Sharmila G, Bhat FA, Arunkumar R, Elumalai P, Raja Singh P, Senthilkumar K, Arunakaran J,. Chemopreventive effect of quercetin, a natural dietary flavonoid on prostate cancer in in vivo model. Clin Nutr 2013.
17. Ward AB,. The effects of quercetin on prostate cancer. Cancer Research 2014; 74: Abstract 2128.
18. Senthilkumar K, Elumalai P, Arunkumar R, Banudevi S, Gunadharini ND, Sharmila G, Selvakumar K, Arunakaran J,. Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3). Mol Cell Biochem 2010; 344: 173-184.
19. Bhat FA, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S, Raja Singh P, Srinivasan N, Arunakaran J,. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem 2014.
20. Wang P, Vadgama JV, Said JW, Magyar CE, Doan N, Heber D, Henning SM,. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J Nutr Biochem 2014; 25: 73-80.
21. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J,. Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial. Urology 1999; 54: 960-963.
22. Beyene D, Daremipouran M, Apprey V, Williams R, Ricks-Santi L, Kassim OO, Naab TJ, Kanaan YM, Copeland RL, Jr., Use of tanning potential as a predictor for prostate cancer risk in African-American men. In Vivo 2014; 28: 1181-1187.
23. Colli JL, Colli A,. International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urol Oncol 2006; 24: 184-194.
24. Holick MF,. Vitamin D: Photobiology, metabolism, etc., In "Primer on the metabolic bone diseases and disorders of mineral metabolism." American Society for Bone and Mineral Research, 3rd edition. Philadelphia, PA: Lippincott-Raven; 1996. pp. 74-81.
25. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R,. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-716.
26. Holick MF, Chen TC,. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086S.
27. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L,. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124: 453-469.
28. Coates RJ, Eley JW, Block G, Gunter EW, Sowell AL, Grossman C, Greenberg RS,. An evaluation of a food frequency questionnaire for assessing dietary intake of specific carotenoids and vitamin E among low-income black women. Am J Epidemiol 1991; 134: 658-671.
29. McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS, Graham S,. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 2005; 53: 33-41.
30. Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC, Hursting SD,. Phytoestrogen intake and prostate cancer: A case-control study using a new database. Nutr Cancer 1999; 33: 20-25.
31. Singh B, Mense SM, Bhat NK, Putty S, Guthiel WA, Remotti F, Bhat HK,. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol Appl Pharmacol 2010; 247: 83-90.